0001209191-18-002047.txt : 20180104 0001209191-18-002047.hdr.sgml : 20180104 20180104170829 ACCESSION NUMBER: 0001209191-18-002047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180102 FILED AS OF DATE: 20180104 DATE AS OF CHANGE: 20180104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAYDEN DONALD J JR CENTRAL INDEX KEY: 0001202285 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 18510942 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 662-2000 MAIL ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-02 0 0001178879 AMICUS THERAPEUTICS INC FOLD 0001202285 HAYDEN DONALD J JR C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 1 0 0 0 Common Stock 2018-01-02 4 M 0 20000 15.0001 A 25814 D Common Stock 2018-01-02 4 S 0 20000 15.0001 D 5814 D Stock Options (right to buy) 7.15 2018-01-02 4 M 0 10000 0.00 D 2010-06-10 2019-06-10 Common Stock 10000 0 D Stock Options (right to buy) 10.53 2018-01-02 4 M 0 10000 0.00 D 2009-06-10 2018-06-10 Common Stock 10000 0 D The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2017. This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.01. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.00 to $15.01. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Donald J. Hayden 2018-01-04